Drug Topics Advisory Board member Phil Burgess has been appointed to the American Pharmacists Association (APhA) Health Information Technology Advisory Panel.
Drug Topics
Advisory Board member Philip Burgess has been appointed to the American Pharmacists Association (APhA) Health Information Technology Advisory Panel.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.